High prevalence of Bordetella pertussis in children under 5years old hospitalized with acute respiratory infections in Lima, Peru

Ivana Pavic-Espinoza, Sandy Bendezú-Medina, Angella Herrera-Alzamora, Pablo Weilg, María J. Pons, Miguel Angel Aguilar-Luis, Verónica Petrozzi-Helasvuo, Juana del Valle Mendoza

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Background: Pertussis diagnosis may go unrecognized when other pathogens, such as respiratory syncytial virus (RSV) circulate. Methods: A prospective cross-sectional study was conducted in Lima, Peru from January 2009 to September 2010. A total of 596 children under 5years old admitted with clinical diagnoses of acute respiratory infections were test for B. pertussis and RSV detection by polymerase chain reaction (PCR). Results: The pertussis toxin and IS481 genes were detected in 19.12% (114/596) of the cases and the respiratory syncytial viruses (RSV-A and RSV-B) were identified in 17.28% (103/596) of patients. Infants under 3months old were the most frequently affected by this pathogens in 43% (49/114) and 35.9% (37/103) respectively. An increase of B. pertussis was observed from February to March and from October to November with a Seasonal index between 1.32 and 1.51 and 1.24-3.5 respectively. Conclusions: Epidemiologic surveillance for B. pertussis is essential in Peru, especially in children that could most benefit from the vaccine. B. pertussis should be suspected in infants hospitalized for acute respiratory symptoms for early treatment and prevent complications.

Original languageEnglish
Article number554
JournalBMC Infectious Diseases
Volume15
Issue number1
DOIs
StatePublished - 2 Dec 2015

Keywords

  • Bordetella pertussis
  • Bronchiolitis
  • Infants
  • Vaccine

Fingerprint

Dive into the research topics of 'High prevalence of Bordetella pertussis in children under 5years old hospitalized with acute respiratory infections in Lima, Peru'. Together they form a unique fingerprint.

Cite this